CME Group CME
Valuation
Multiples measured against the stock's own five-year history
Around its usual level · 47th percentile, 5-year average 25.6x
#1884 of 2972 stocks by PE (1 = cheapest)
Near the top of its 5-year range · 100th percentile, 5-year average 3.0x
#4131 of 5311 stocks by PB (1 = cheapest)
Above its usual level · 77th percentile, 5-year average 14.6x
#4641 of 5150 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 4.09 | – | 3.00 | 100% (pricier than usual) | #4131 of 5311 (1 = cheapest) |
| PE | 24.85 | 23.69 | 25.59 | 47% (cheaper than usual) | #1884 of 2972 (1 = cheapest) |
| PS | 15.56 | 14.83 | 14.60 | 77% (pricier than usual) | #4641 of 5150 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on CME.
Sign in to join the discussion.